JAN PIXTON: Open Payments
NPI 1497828511 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,194 in 102 payments from 27 companies in 2025. Trend: 2023 $2,197 · 2024 $2,281 · 2025 $2,194
Food & beverage: $2,194
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $265 |
| AstraZeneca Pharmaceuticals LP | 10 | $234 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $223 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $209 |
| PFIZER INC. | 4 | $179 |
| ABBVIE INC. | 13 | $172 |
| Novo Nordisk Inc | 11 | $170 |
| Lilly USA, LLC | 6 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Aimmune Therapeutics, Inc. | 3 | $65 |
Products named: CAPLYTA, Kerendia, XIFAXAN, NURTEC ODT, JARDIANCE, BREZTRI, Wegovy, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
